Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maron

Showing results (311-320 of 3,459) with videos related to

Pageof 346
Sort By:
JACC. Basic to Translational Science|December 14, 2023
Inhibiting Serotonin to Treat Pulmonary Arterial Hypertension: An Exciting New Chapter in an Old StoryBradley A Maron
Clinical Therapeutics|November 6, 2024
Silver Linings: Side Effects and Secondary Findings of Newly Emerging TherapiesJill L Maron
Clinical Therapeutics|August 17, 2025
Now What? Utilizing Adverse Drug Reporting Databases to Inform Care, Update Guidelines, and Improve OutcomesJill L Maron
Clinical Therapeutics|March 12, 2023
Weighing in on the Scale of Justice for Equity and Access to Weight-management DrugsJill L Maron
Current Opinion in Pulmonary Medicine|July 7, 2025
Precision medicine in pulmonary hypertension: how close are we today?Bradley A Maron
Clinical Therapeutics|February 18, 2026
The Use of Ensemble Large Language Models to Predict Patient NonadherenceJill L Maron
Circulation|July 6, 2026
A New <i>Circulation</i>, For YouBradley A Maron
Heart (British Cardiac Society)|October 21, 2022
Differing strategies for sudden death prevention in hypertrophic cardiomyopathyMartin S Maron, Ethan Rowin, Paolo Spirito, et al.
The American Journal of Cardiology|February 24, 2018
Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field?Barry J Maron, N A Mark Estes, Martin S Maron
Journal of the American College of Cardiology|October 21, 2015
Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?Christopher Semsarian, Jodie Ingles, Martin S Maron, et al.
Pageof 346

Showing results (311-320 of 3,459) with videos related to

Sort By:
Pageof 346
JACC. Basic to Translational Science|December 14, 2023
Inhibiting Serotonin to Treat Pulmonary Arterial Hypertension: An Exciting New Chapter in an Old StoryBradley A Maron
Clinical Therapeutics|November 6, 2024
Silver Linings: Side Effects and Secondary Findings of Newly Emerging TherapiesJill L Maron
Clinical Therapeutics|August 17, 2025
Now What? Utilizing Adverse Drug Reporting Databases to Inform Care, Update Guidelines, and Improve OutcomesJill L Maron
Clinical Therapeutics|March 12, 2023
Weighing in on the Scale of Justice for Equity and Access to Weight-management DrugsJill L Maron
Current Opinion in Pulmonary Medicine|July 7, 2025
Precision medicine in pulmonary hypertension: how close are we today?Bradley A Maron
Clinical Therapeutics|February 18, 2026
The Use of Ensemble Large Language Models to Predict Patient NonadherenceJill L Maron
Circulation|July 6, 2026
A New <i>Circulation</i>, For YouBradley A Maron
Heart (British Cardiac Society)|October 21, 2022
Differing strategies for sudden death prevention in hypertrophic cardiomyopathyMartin S Maron, Ethan Rowin, Paolo Spirito, et al.
The American Journal of Cardiology|February 24, 2018
Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field?Barry J Maron, N A Mark Estes, Martin S Maron
Journal of the American College of Cardiology|October 21, 2015
Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?Christopher Semsarian, Jodie Ingles, Martin S Maron, et al.
Pageof 346